DK0833626T3 - Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelser - Google Patents
Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelserInfo
- Publication number
- DK0833626T3 DK0833626T3 DK96922001T DK96922001T DK0833626T3 DK 0833626 T3 DK0833626 T3 DK 0833626T3 DK 96922001 T DK96922001 T DK 96922001T DK 96922001 T DK96922001 T DK 96922001T DK 0833626 T3 DK0833626 T3 DK 0833626T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- bone matrix
- anthraquions
- disulfo
- mono
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001357A IT1276781B1 (it) | 1995-06-23 | 1995-06-23 | Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie |
| PCT/EP1996/002597 WO1997000675A1 (en) | 1995-06-23 | 1996-06-17 | Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0833626T3 true DK0833626T3 (da) | 2003-06-30 |
Family
ID=11371864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96922001T DK0833626T3 (da) | 1995-06-23 | 1996-06-17 | Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5856358A (ru) |
| EP (1) | EP0833626B1 (ru) |
| JP (1) | JP3307650B2 (ru) |
| AT (1) | ATE233553T1 (ru) |
| AU (1) | AU6303996A (ru) |
| CA (1) | CA2225277A1 (ru) |
| CZ (1) | CZ293326B6 (ru) |
| DE (1) | DE69626514T2 (ru) |
| DK (1) | DK0833626T3 (ru) |
| ES (1) | ES2193248T3 (ru) |
| IT (1) | IT1276781B1 (ru) |
| MX (1) | MX9800049A (ru) |
| PT (1) | PT833626E (ru) |
| RU (1) | RU2202534C2 (ru) |
| SK (1) | SK281853B6 (ru) |
| WO (1) | WO1997000675A1 (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9608133D0 (en) * | 1996-04-19 | 1996-06-26 | Gemini International Holdings | Diagnostic method and apparatus |
| FR2757397B1 (fr) * | 1996-12-23 | 1999-03-05 | Mazal Pharma | Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree |
| JPH11236333A (ja) * | 1997-12-30 | 1999-08-31 | Pfizer Prod Inc | 抗ガン剤として有用なイミダゾリン−４−オン誘導体 |
| US6117869A (en) * | 1998-08-04 | 2000-09-12 | Warner-Lambert Company | Compounds for and methods of inhibiting matrix metalloproteinases |
| US6174903B1 (en) | 1998-12-28 | 2001-01-16 | Pfizer Inc. | Imidazolidin-4-one derivatives useful as anticancer agents |
| US6610750B1 (en) * | 2000-09-15 | 2003-08-26 | Laboratoires Negma | Treatment of osteoarthritis |
| AUPR229600A0 (en) * | 2000-12-22 | 2001-01-25 | Commonwealth Scientific And Industrial Research Organisation | New oxygen scavenging compositions |
| US6600057B2 (en) * | 2000-12-29 | 2003-07-29 | Kimberly-Clark Worldwide, Inc. | Matrix metalloproteinase inhibitors |
| US8790714B2 (en) * | 2007-08-03 | 2014-07-29 | Nucitec, S.A. De C.V. | Compositions and methods for treatment and prevention of osteoarthritis |
| CA2781706A1 (en) * | 2009-11-24 | 2011-06-03 | The Ohio State University | Transcription factor inhibitors and related compositions, formulations and methods |
| KR101567925B1 (ko) * | 2010-04-08 | 2015-11-10 | 티더블유아이 바이오테크놀로지 인코포레이티드 | 당뇨병 보조치료요법으로서 디아세레인을 사용하는 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2025954A (en) * | 1978-07-21 | 1980-01-30 | Ciba Geigy Ag | Anthraquinone Sulphonamides |
| IT1244773B (it) * | 1991-03-12 | 1994-08-08 | Gentili Ist Spa | N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari |
-
1995
- 1995-06-23 IT IT95MI001357A patent/IT1276781B1/it active IP Right Grant
-
1996
- 1996-06-17 US US08/981,287 patent/US5856358A/en not_active Expired - Fee Related
- 1996-06-17 DK DK96922001T patent/DK0833626T3/da active
- 1996-06-17 DE DE69626514T patent/DE69626514T2/de not_active Expired - Fee Related
- 1996-06-17 PT PT96922001T patent/PT833626E/pt unknown
- 1996-06-17 RU RU98101090/14A patent/RU2202534C2/ru not_active IP Right Cessation
- 1996-06-17 CZ CZ19974193A patent/CZ293326B6/cs not_active IP Right Cessation
- 1996-06-17 SK SK1760-97A patent/SK281853B6/sk unknown
- 1996-06-17 CA CA002225277A patent/CA2225277A1/en not_active Abandoned
- 1996-06-17 AU AU63039/96A patent/AU6303996A/en not_active Abandoned
- 1996-06-17 JP JP50356397A patent/JP3307650B2/ja not_active Expired - Fee Related
- 1996-06-17 EP EP96922001A patent/EP0833626B1/en not_active Expired - Lifetime
- 1996-06-17 AT AT96922001T patent/ATE233553T1/de not_active IP Right Cessation
- 1996-06-17 ES ES96922001T patent/ES2193248T3/es not_active Expired - Lifetime
- 1996-06-17 WO PCT/EP1996/002597 patent/WO1997000675A1/en active IP Right Grant
-
1998
- 1998-01-07 MX MX9800049A patent/MX9800049A/es not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0833626A1 (en) | 1998-04-08 |
| WO1997000675A1 (en) | 1997-01-09 |
| ITMI951357A0 (it) | 1995-06-23 |
| CZ293326B6 (cs) | 2004-04-14 |
| DE69626514T2 (de) | 2003-12-24 |
| CA2225277A1 (en) | 1997-01-09 |
| AU6303996A (en) | 1997-01-22 |
| SK281853B6 (sk) | 2001-08-06 |
| SK176097A3 (en) | 1998-06-03 |
| DE69626514D1 (de) | 2003-04-10 |
| EP0833626B1 (en) | 2003-03-05 |
| ATE233553T1 (de) | 2003-03-15 |
| JP3307650B2 (ja) | 2002-07-24 |
| ITMI951357A1 (it) | 1996-12-23 |
| CZ419397A3 (cs) | 1998-07-15 |
| JPH11509186A (ja) | 1999-08-17 |
| PT833626E (pt) | 2003-07-31 |
| MX9800049A (es) | 1998-11-30 |
| IT1276781B1 (it) | 1997-11-03 |
| US5856358A (en) | 1999-01-05 |
| RU2202534C2 (ru) | 2003-04-20 |
| ES2193248T3 (es) | 2003-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971766D0 (no) | Anvendelsen av dioksomorfoliner for bekjempning av endoparasitter, nye dioksomorfoliner samt deres fremstilling | |
| BR9408246A (pt) | Composto derivado de 3-azabicicloalcano N-substituído | |
| ATE185797T1 (de) | Stilben-derivate verwendbar als cyclooxygenase-2 hemmer | |
| DE69505542D1 (de) | 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten | |
| DK0833626T3 (da) | Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelser | |
| ES2143666T3 (es) | P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales. | |
| DK0775143T3 (da) | 3-substituerede 3H-2,3-benzodiazepinderivater, deres fremstilling og anvendelse som lægdemidler | |
| DE59509186D1 (de) | N-substituierte azabicycloheptan-derivate als neuroleptika usw. | |
| PE57194A1 (es) | Hidroxiurea de fenoxifenil ciclopentenil | |
| DK0668852T3 (da) | Substituerede orthoethenylphenyleddikesyrederivater | |
| DK0623118T3 (da) | Carbamatderivater og deres anvendelse i medicin | |
| DK0417875T3 (da) | 1-methoxypyrimidinyl-1H-1,2,4-triazol-3-sulfonsyrenitroanilider, fremgangsmåde til fremstilling heraf og deres anvendelse som middel med herbicid virkning | |
| DK0691846T3 (da) | Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet |